Company Analysis STAAR Surgical Company
1. Summary
Advantages
- The company's current efficiency (ROE=5.53%) is higher than the sector average (ROE=-80.87%)
Disadvantages
- Price (41.52 $) is higher than fair price (5.37 $)
- Dividends (0%) are below the sector average (1.28%).
- The stock's return over the last year (-21.18%) is lower than the sector average (-13.41%).
- Current debt level 7.33% has increased over 5 years from 3.17%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| STAAR Surgical Company | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0% | -12% | 0.7% |
| 90 days | -26.3% | -19.6% | 2.6% |
| 1 year | -21.2% | -13.4% | 25.8% |
STAA vs Sector: STAAR Surgical Company has significantly underperformed the "Healthcare" sector by -7.77% over the past year.
STAA vs Market: STAAR Surgical Company has significantly underperformed the market by -46.96% over the past year.
Stable price: STAA is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: STAA with weekly volatility of -0.4073% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (41.52 $) is higher than the fair price (5.37 $).
Price is higher than fair: The current price (41.52 $) is 87.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (73.24) is higher than that of the sector as a whole (57.85).
P/E vs Market: The company's P/E (73.24) is higher than that of the market as a whole (47.37).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.05) is lower than that of the sector as a whole (9.39).
P/BV vs Market: The company's P/BV (4.05) is lower than that of the market as a whole (22.69).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (4.85) is higher than that of the sector as a whole (4.05).
P/S vs Market: The company's P/S indicator (4.85) is lower than that of the market as a whole (15.16).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (42.63) is higher than that of the sector as a whole (17.49).
EV/Ebitda vs Market: The company's EV/Ebitda (42.63) is higher than that of the market as a whole (17.77).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 10.5% over the last 5 years.
Earnings Slowdown: The last year's return (0.2207%) is below the 5-year average return (10.5%).
Profitability vs Sector: The return for the last year (0.2207%) exceeds the return for the sector (-69.16%).
5.4. ROE
ROE vs Sector: The company's ROE (5.53%) is higher than that of the sector as a whole (-80.87%).
ROE vs Market: The company's ROE (5.53%) is lower than that of the market as a whole (17.14%).
5.5. ROA
ROA vs Sector: The company's ROA (4.37%) is lower than that of the sector as a whole (6.7%).
ROA vs Market: The company's ROA (4.37%) is lower than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.28%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0.0453%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 21.09.2023 | Lin Elizabeth Yeu Director |
Purchase | 40 | 100 000 | 2 500 |
| 21.09.2023 | BROADWOOD PARTNERS, L.P. 10% Owner |
Purchase | 39.62 | 6 133 730 | 154 814 |
| 20.09.2023 | BROADWOOD PARTNERS, L.P. 10% Owner |
Purchase | 40.67 | 5 371 650 | 132 079 |
| 19.09.2023 | BROADWOOD PARTNERS, L.P. 10% Owner |
Purchase | 40.89 | 183 596 | 4 490 |
| 07.09.2023 | BROADWOOD PARTNERS, L.P. 10% Owner |
Purchase | 41.26 | 2 511 660 | 60 874 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
